West Pharma (WST) Tops Q1 EPS by 33c
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $329.71 +0.54%
Revenue Growth %: +9.5%
Financial Fact:
Interest income: 200K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +9.5%
Financial Fact:
Interest income: 200K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q1 EPS of $1.98, $0.33 better than the analyst estimate of $1.65. Revenue for the quarter came in at $716.6 million versus the consensus estimate of $691.67 million.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- AXT appoints Tracy Liu to its board of directors
- Alphabet slides over 6% as AI brain drain and SpaceX slump converge
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
